Sopheon has been acquired by Wellspring Worldwide
The shareholders of Sophean plc. have sold the company to Wellspring Worldwide.
Sopheon is a global enterprise software and services company focused on delivering InnovationOps. It has offices in Denver and Minneapolis in the US. The company also has operating units in the UK, Netherlands, Germany and Australia.
Founded in 2003, Wellspring provides open innovation software to identify, evaluate and share knowledge assets. Its solutions are used by over 500 organizations every day for tech scouting, corporate venturing, licensing and intellectual property management. Wellspring’s clients include Fortune 500 companies, SMEs, hospitals, government agencies and universities.
Oaklins Cavendish, based in the UK, acted as sell-side advisor in this transaction.
Talk to the deal team
Related deals
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreOSL has been acquired by Terma
OSL Group Limited, a leader in counter-drone security and safety systems, has been acquired by Terma AS, a Denmark-based global provider of mission-critical solutions for defense, aerospace and security.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more